Novavax Files COVID-19 Vaccine for Provisional Approval in New Zealand

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. MU
3. SPCX
4. ACN
5. IBM
6. DPZ
7. NVDA
8. PRIM
9. META
10. SPY

Go back to Novavax Files COVID-19 Vaccine for Provisional Approval in New Zealand
Novavax, Inc. (NASDAQ: NVAX) Delayed: 9.33 +0.33 (3.67%)
Previous Close $9.00    52 Week High $9.23 
Open $8.81    52 Week Low $1.16 
Day High $9.59    P/E N/A 
Day Low $8.81    EPS $-0.30 
Volume 1,540,297